Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)
Not Applicable
Suspended
- Conditions
- Retinal Detachment
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- BioFirst Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT05414747
- Locations
- 🇦🇺
Sydney Eye Hospital, Syd, New South Wales, Australia
🇦🇺East Melbourne Eye Group, Melbourne, Victoria, Australia
🇹🇭Ramathibodi Hospital, Bangkok, Thailand
A Phase I Study of Vitargus® in Vitrectomy
Not Applicable
Completed
- Conditions
- Vitreo-retinal Surgery
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- BioFirst Corporation
- Target Recruit Count
- 11
- Registration Number
- NCT04481386
- Locations
- 🇦🇺
Sydney Retina Clinic and Day Surgery, Sydney, New South Wales, Australia
News
ABVC BioPharma Receives $150K Milestone Payment, Advancing Botanical CNS Therapies Through Strategic Partnerships
ABVC BioPharma received a $150,000 milestone payment from AiBtl BioPharma, bringing total licensing revenue to $846,000 across strategic partnerships.